- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有189家主力机构披露2025-12-31报告期持股数据，持仓量总计1297.96万股，占流通A股2.29%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了60%的股票
技术面评分前10的股票
近期的平均成本为42.25元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为42.25元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"42.25","date":1778142762,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.05.08","stock":"0.50","trade":"0.79","ind":"-0.00"},{"date":"2026.05.07","stock":"0.43","trade":"-0.27","ind":"0.48"},{"date":"2026.05.06","stock":"3.08","trade":"-0.14","ind":"1.17"},{"date":"2026.04.30","stock":"1.60","trade":"0.43","ind":"0.11"},{"date":"2026.04.29","stock":"0.18","trade":"0.63","ind":"0.71"},{"date":"2026.04.28","stock":"2.26","trade":"0.26","ind":"-0.19"},{"date":"2026.04.27","stock":"-2.06","trade":"-0.18","ind":"0.16"},{"date":"2026.04.24","stock":"-1.31","trade":"-0.04","ind":"-0.33"},{"date":"2026.04.23","stock":"-0.37","trade":"-0.87","ind":"-0.32"},{"date":"2026.04.22","stock":"-0.42","trade":"0.13","ind":"0.52"},{"date":"2026.04.21","stock":"0.30","trade":"-0.57","ind":"0.07"},{"date":"2026.04.20","stock":"-0.34","trade":"0.15","ind":"0.76"},{"date":"2026.04.17","stock":"-1.09","trade":"-1.52","ind":"-0.10"},{"date":"2026.04.16","stock":"-0.94","trade":"-0.13","ind":"0.70"},{"date":"2026.04.15","stock":"1.76","trade":"2.03","ind":"0.01"},{"date":"2026.04.14","stock":"0.39","trade":"0.36","ind":"0.95"},{"date":"2026.04.13","stock":"-1.12","trade":"-1.82","ind":"0.06"},{"date":"2026.04.10","stock":"0.15","trade":"0.01","ind":"0.51"},{"date":"2026.04.09","stock":"-1.18","trade":"-1.54","ind":"-0.72"},{"date":"2026.04.08","stock":"2.04","trade":"0.62","ind":"2.70"},{"date":"2026.04.07","stock":"-0.92","trade":"0.87","ind":"0.26"}]
达仁堂,上证指数,中药指数
压力支撑
该股压力位为42.15元，支撑位为41.75元。
[{"text":"\u538b\u529b\u4f4d","value":"42.15","date":1778169600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"41.75","date":1778169600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.1资金面打败了36%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月08日 17:25
| 机构今日流向(万元) | -1544.30 | 机构5日流向(万元) | -4630.56 |
| 机构10日流向(万元) | -7371.56 | 机构20日流向(万元) | -20965.73 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少381.45万股，其中基金净减仓42家，主力净增仓38家，暂未发现中长期投资价值。
截止2025-12-31，共189家主力机构（基金189家），持仓量总计1297.96万股，占流通A股2.29%
其中，基金持仓与2025-06-30相比：
增仓：24家 ，增持 123.01万股
减仓：66家 ，减持 149.29万股
新出现在主力名单中：97家 ，持有249.7万股
从主力名单中消失：59家 ，原持有604.87万股
其中，基金持仓与2025-06-30相比：
增仓：24家 ，增持 123.01万股
减仓：66家 ，减持 149.29万股
新出现在主力名单中：97家 ，持有249.7万股
从主力名单中消失：59家 ，原持有604.87万股
消息面诊股
诊断结果：5.8消息面打败了36%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 达仁堂：5月7日获融资买入1319.17万元
2026-05-08 - 达仁堂：5月6日获融资买入1364.55万元
2026-05-07 - 4月中医药政策资讯
2026-05-06 - 年报披露完毕高股息公司出炉，最高达到11.8% （
2026-05-06 - A股“现金奶牛”榜单曝光，4只个股股息率超10%
2026-05-03 - 达仁堂一季度营业收入15.15亿元，同比增长4.1
2026-05-03 - 600329，股息率高达11.8%！上市以来分红不
2026-05-01 - 【数说年报】高股息率公司出炉：18家超7% 最高达
2026-05-01 - 达仁堂：4月30日获融资买入1392.66万元
2026-05-01 - 达仁堂：4月29日获融资买入553.59万元
2026-04-30
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-17 |
| 一般消息 | 募资投向 | 2026-04-02 | |
| 利好 | 分红转增 | 10派23.4元(含税) | 2026-03-31 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-15 |
| 利好 | 分红转增 | 10派24.5元(含税) | 2025-10-31 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-21 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-16 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.3行业面打败了74%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.05.08","price":"-0.00","value":"0.79"},{"date":"2026.05.07","price":"0.48","value":"-0.27"},{"date":"2026.05.06","price":"1.17","value":"-0.14"},{"date":"2026.04.30","price":"0.11","value":"0.43"},{"date":"2026.04.29","price":"0.71","value":"0.63"},{"date":"2026.04.28","price":"-0.19","value":"0.26"},{"date":"2026.04.27","price":"0.16","value":"-0.18"},{"date":"2026.04.24","price":"-0.33","value":"-0.04"},{"date":"2026.04.23","price":"-0.32","value":"-0.87"},{"date":"2026.04.22","price":"0.52","value":"0.13"},{"date":"2026.04.21","price":"0.07","value":"-0.57"},{"date":"2026.04.20","price":"0.76","value":"0.15"},{"date":"2026.04.17","price":"-0.10","value":"-1.52"},{"date":"2026.04.16","price":"0.70","value":"-0.13"},{"date":"2026.04.15","price":"0.01","value":"2.03"},{"date":"2026.04.14","price":"0.95","value":"0.36"},{"date":"2026.04.13","price":"0.06","value":"-1.82"},{"date":"2026.04.10","price":"0.51","value":"0.01"},{"date":"2026.04.09","price":"-0.72","value":"-1.54"},{"date":"2026.04.08","price":"2.70","value":"0.62"},{"date":"2026.04.07","price":"0.26","value":"0.87"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康惠股份 | 41.97% | 12.38% | 6.3分 |
| 2 | 众生药业 | 20.53% | 19.20% | 5.8分 |
| 3 | 粤万年青 | 16.23% | 20.64% | 5.8分 |
| 4 | 维康药业 | 14.19% | 19.85% | 5.7分 |
| 5 | 济川药业 | 9.61% | 7.11% | 7.0分 |
| 6 | 葵花药业 | 9.43% | 5.93% | 5.7分 |
| 8 | 吉林敖东 | 7.19% | 1.35% | 5.3分 |
| 10 | 天士力 | 6.25% | -1.06% | 6.1分 |
| 12 | 华神科技 | 5.39% | 12.50% | 5.6分 |
| 14 | 汉森制药 | 4.20% | 0.70% | 6.3分 |
| 16 | 恩威医药 | 3.38% | 4.49% | 6.2分 |
| 18 | 亚宝药业 | 3.08% | 1.59% | 6.3分 |
| 20 | 沃华医药 | 2.22% | -1.47% | 5.3分 |
| 22 | 桂林三金 | 1.68% | 3.87% | 6.2分 |
| 24 | 太龙药业 | 1.09% | 6.59% | 5.5分 |
| 26 | 千金药业 | 0.65% | 1.80% | 6.4分 |
| 28 | 方盛制药 | 0.27% | 1.20% | 6.5分 |
| 30 | 康恩贝 | 0.00% | -0.68% | 5.3分 |
| 32 | ST百灵 | -0.40% | -1.00% | 4.8分 |
| 34 | 信邦制药 | -0.60% | 4.72% | 5.8分 |
| 36 | 佐力药业 | -0.78% | 0.00% | 5.4分 |
| 38 | 康缘药业 | -2.01% | -2.01% | 4.7分 |
| 40 | 上海凯宝 | -2.34% | 2.09% | 5.4分 |
| 42 | 东阿阿胶 | -3.00% | -2.15% | 5.5分 |
| 44 | 云南白药 | -3.15% | -1.20% | 6.0分 |
| 46 | 精华制药 | -3.88% | 1.50% | 6.3分 |
| 48 | 天目药业 | -5.06% | 3.08% | 6.1分 |
| 50 | 广誉远 | -5.27% | -2.30% | 5.2分 |
| 52 | 华森制药 | -5.65% | -1.44% | 4.8分 |
| 54 | 片仔癀 | -6.25% | 1.39% | 4.7分 |
| 56 | 盘龙药业 | -6.81% | 5.95% | 5.5分 |
| 58 | 华润江中 | -7.49% | 0.46% | 5.7分 |
| 60 | 华润三九 | -8.00% | -1.69% | 5.5分 |
| 62 | 中恒集团 | -8.37% | -2.03% | 4.4分 |
| 64 | 益佰制药 | -16.77% | -0.95% | 4.3分 |
| 66 | ST金花 | -23.06% | -17.01% | 4.7分 |
| 68 | ST嘉应 | -32.48% | -23.98% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/107 ， 9/107。
[{"date":"2026-03-31","value":"5.80","vol":"2.21"},{"date":"2025-12-31","value":"28.52","vol":"-2.33"},{"date":"2025-09-30","value":"25.54","vol":"4.80"},{"date":"2025-06-30","value":"23.18","vol":"4.03"},{"date":"2025-03-31","value":"4.66","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.80 | 28.52 | 25.54 | 23.18 | 4.66 |
| 行业(%) | 2.21 | -2.33 | 4.80 | 4.03 | 2.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"77.71","vol":"55.05"},{"date":"2025-12-31","value":"74.02","vol":"52.85"},{"date":"2025-09-30","value":"74.98","vol":"53.29"},{"date":"2025-06-30","value":"74.67","vol":"53.82"},{"date":"2025-03-31","value":"73.86","vol":"54.48"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
77.71 | 74.02 | 74.98 | 74.67 | 73.86 |
| 行业(%) | 55.05 | 52.85 | 53.29 | 53.82 | 54.48 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/107 ， 25/107。
[{"date":"2026-03-31","value":"4.12","vol":"-5.58"},{"date":"2025-12-31","value":"-32.70","vol":"-6.76"},{"date":"2025-09-30","value":"-34.59","vol":"-7.84"},{"date":"2025-06-30","value":"-33.15","vol":"-7.78"},{"date":"2025-03-31","value":"-30.22","vol":"-7.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
4.12 | -32.70 | -34.59 | -33.15 | -30.22 |
| 行业(%) | -5.58 | -6.76 | -7.84 | -7.78 | -7.40 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"13.24","vol":"1.06"},{"date":"2025-12-31","value":"-4.41","vol":"-80.25"},{"date":"2025-09-30","value":"167.73","vol":"-2.78"},{"date":"2025-06-30","value":"193.08","vol":"2.25"},{"date":"2025-03-31","value":"-3.38","vol":"-37.69"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
13.24 | -4.41 | 167.73 | 193.08 | -3.38 |
| 行业(%) | 1.06 | -80.25 | -2.78 | 2.25 | -37.69 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 26/107 ， 52/107。
[{"date":"2026-03-31","value":"0.14","vol":"0.12"},{"date":"2025-12-31","value":"0.44","vol":"0.47"},{"date":"2025-09-30","value":"0.33","vol":"0.35"},{"date":"2025-06-30","value":"0.22","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.44 | 0.33 | 0.22 | 0.13 |
| 行业(次) | 0.12 | 0.47 | 0.35 | 0.24 | 0.13 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.31","vol":"0.59"},{"date":"2025-12-31","value":"1.06","vol":"2.34"},{"date":"2025-09-30","value":"0.74","vol":"1.72"},{"date":"2025-06-30","value":"0.54","vol":"1.17"},{"date":"2025-03-31","value":"0.31","vol":"0.59"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.31 | 1.06 | 0.74 | 0.54 | 0.31 |
| 行业(次) | 0.59 | 2.34 | 1.72 | 1.17 | 0.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"27.86","vol":"5.83"},{"date":"2025-12-31","value":"-10.36","vol":"30.77"},{"date":"2025-09-30","value":"10.06","vol":"10.53"},{"date":"2025-06-30","value":"11.06","vol":"22.82"},{"date":"2025-03-31","value":"24.43","vol":"2.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 27.86 | -10.36 | 10.06 | 11.06 | 24.43 |
| 行业 | 5.83 | 30.77 | 10.53 | 22.82 | 2.06 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.95","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.71","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.95 | - | 0.71 | - |
| 行业 | 0.00 | 1.00 | 0.00 | 1.03 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/107 ， 4/107。
[{"date":"2026-03-31","value":"2.16","vol":"2.97"},{"date":"2025-12-31","value":"1.59","vol":"2.94"},{"date":"2025-09-30","value":"2.81","vol":"3.09"},{"date":"2025-06-30","value":"2.06","vol":"2.94"},{"date":"2025-03-31","value":"2.00","vol":"3.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.16 | 1.59 | 2.81 | 2.06 | 2.00 |
| 行业 | 2.97 | 2.94 | 3.09 | 2.94 | 3.03 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.96","vol":"2.23"},{"date":"2025-12-31","value":"0.58","vol":"2.15"},{"date":"2025-09-30","value":"1.08","vol":"2.24"},{"date":"2025-06-30","value":"1.37","vol":"2.15"},{"date":"2025-03-31","value":"1.11","vol":"2.24"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.96 | 0.58 | 1.08 | 1.37 | 1.11 |
| 行业 | 2.23 | 2.15 | 2.24 | 2.15 | 2.24 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/107 ， 33/107。
[{"date":"2026-03-31","value":"27.92","vol":"31.94"},{"date":"2025-12-31","value":"39.26","vol":"32.43"},{"date":"2025-09-30","value":"22.11","vol":"31.59"},{"date":"2025-06-30","value":"31.53","vol":"32.45"},{"date":"2025-03-31","value":"26.38","vol":"31.91"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
27.92 | 39.26 | 22.11 | 31.53 | 26.38 |
| 行业(%) | 31.94 | 32.43 | 31.59 | 32.45 | 31.91 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.39","vol":"0.66"},{"date":"2025-12-31","value":"0.65","vol":"0.67"},{"date":"2025-09-30","value":"0.28","vol":"0.76"},{"date":"2025-06-30","value":"0.46","vol":"0.75"},{"date":"2025-03-31","value":"0.36","vol":"0.74"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.39 | 0.65 | 0.28 | 0.46 | 0.36 |
| 行业(%) | 0.66 | 0.67 | 0.76 | 0.75 | 0.74 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"9.87","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"22.29","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"21.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"11.03","blueLineValue":"1.43","type":"YC"}]